BP000148-CYT-173: Recombinant Rat Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
The biological activity is measured by its ability to induce IL-10 secretion in COLO 205 (human colon carcinoma cells). The expected ED50 for this effect is 0.15-0.75 ug/ml.
Purity: > 97.0% as determined by RP-HPLC and SDS-PAGE.BP000148-CYT-148: Recombinant Mouse Interleukin-22 (IL-22) Protein
Source: E. coli-derived.
Purity: > 98.0% as determined byGel filtration chromatography under non-denaturing conditions and reducing and non-reducing SDS-PAGE Silver Stained gel. <BP000147-CYT-033: Recombinant Rat IL-21
Source: E. coli-derived.
The biological activity is measured by its ability to proliferate activated B cells.
Purity: > 95.0% as determined by RP-HPLC and SDS-PAGE.BP000147-CYT-684: Recombinant Mouse IL-21
Source: E. coli-derived.
The ED50=10-50 ug/ml, determined by the cell proliferation assay of modified Ba/F3 cells.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000147-CYT-408: Recombinant Human IL-21
Source: E. coli-derived.
The ED50=1-10 ug/ml corresponding to a Specific Activity of 0.1-1 MIU/mg , determined by the dose-dependant proliferation of human peripheral blood mononuclear cells.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000146-CYT-347: Recombinant Human Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
The Biological Activity was determined by measuring the dose dependent activation of STAT3 in human epidermal keratinocytes (HEKa cells).Significant STAT3 activation is observed with 100 ug/ml of recombinant human IL-20 corresponding to a Specific Activity of 10,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000146-CYT-379: Recombinant Mouse Interleukin-20 (IL-20) Protein
Source: E. coli-derived.
The biological activity was determined by measuring the dose dependent activation of STAT3 in human epidermal keratinocytes (HEK2a cells). Significant STAT3 activation is observed with >100 ug/ml corresponding to a specific activity of 1,000 U/mg of Interleukin-20 recombinant mouse.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000145-CYT-370: Recombinant Mouse Interleukin-2 (IL-2) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine CTLL-2 cells is 0.18 ug/ml corresponding to a Specific Activity of 55 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000145-CYT-397: Recombinant Porcine Interleukin-2 (IL-2) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant murine CTLL cells proliferation assay with MTS detection is < 0.1 ug/ml, corresponding to a Specific Activity of 10 MIU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000145-CYT-209: Recombinant Human Interleukin-2 (IL-2) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine CTLL-2 cells is < 0.0645 ug/ml, corresponding to a Specific Activity of 15.5 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.